BioAtla receives Nasdaq delisting notice for failing $10M equity requirement

BioAtla, Inc.

Stockholders' equity was $547K as of March 31, 2025, far below the $10M minimum for Nasdaq Global Market.
Company has until June 26, 2025 to submit a compliance plan; Nasdaq may grant a 180-day extension.
No immediate delisting effect; company intends to submit plan and take reasonable measures to regain compliance.
Also failed alternative compliance standards based on market value of listed securities or total assets and revenue.
Risk of delisting persists if plan is not accepted or compliance not regained within any granted period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.